Cellectar Biosciences, Inc. (CLRB) › Net IncomeCellectar Biosciences, Inc. (CLRB) — Net IncomeAnnual figures by fiscal year, from SEC filings.2003: -$295.8K2004: -$342.8K2005: -$481.8K2006: -$963.4K2007: -$5.09M2008: -$6.09M2009: -$6.22M2010: -$4.56M2011: -$7.44M2012: -$8.80M2013: -$10.78M2014: -$8.05M2015: -$5.50M2016: -$6.18M2017: -$13.56M2018: -$13.24M2019: -$14.09M2020: -$15.09M2021: -$24.12M2022: -$31.79M2023: -$42.77M2024: -$44.58M2025: -$21.79M-$21.79M2003Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$21.79M+51.1%2024-$44.58M-4.2%2023-$42.77M-34.5%2022-$31.79M-31.8%2021-$24.12M-59.8%2020-$15.09M-7.1%2019-$14.09M-6.4%2018-$13.24M+2.4%2017-$13.56M-119.4%2016-$6.18M-12.5%2015-$5.50M+31.8%2014-$8.05M+25.3%2013-$10.78M-22.6%2012-$8.80M-18.3%2011-$7.44M-63.0%2010-$4.56M+26.7%2009-$6.22M-2.1%2008-$6.09M-19.7%2007-$5.09M-428.3%2006-$963.4K-100.0%2005-$481.8K-40.6%2004-$342.8K-15.9%2003-$295.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share